156 related articles for article (PubMed ID: 11498517)
1. Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats.
Muscará MN; Lovren F; McKnight W; Dicay M; del Soldato P; Triggle CR; Wallace JL
Br J Pharmacol; 2001 Aug; 133(8):1314-22. PubMed ID: 11498517
[TBL] [Abstract][Full Text] [Related]
2. Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs.
Keeble J; Al-Swayeh OA; Moore PK
Br J Pharmacol; 2001 Aug; 133(7):1023-8. PubMed ID: 11487511
[TBL] [Abstract][Full Text] [Related]
3. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
4. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
6. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
7. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
8. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
9. Enhanced responses to L-arginine in aortic rings from rats with angiotensin-dependent hypertension.
Pucci ML; Dick LB; Miller KB; Smith CJ; Nasjletti A
J Pharmacol Exp Ther; 1995 Jul; 274(1):1-7. PubMed ID: 7616384
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-releasing aspirin inhibits vasoconstriction in perfused tail artery of normotensive and spontaneously hypertensive rats.
Rossoni G; Manfredi B; Del Soldato P; Polvani G; Berti F
Eur J Pharmacol; 2003 Sep; 477(1):59-68. PubMed ID: 14512099
[TBL] [Abstract][Full Text] [Related]
11. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive and antihypertensive potential of 4-[(1-phenyl-1H-pyrazol-4-yl) methyl]1-piperazine carboxylic acid ethyl ester: a piperazine derivative.
Fajemiroye JO; Amaral NO; da Silva EF; Galdino PM; de Oliveira TS; Ghedini PC; Zjawiony JK; Costa EA; Pedrino GR; Menegatti R
Life Sci; 2014 Sep; 112(1-2):90-6. PubMed ID: 25072354
[TBL] [Abstract][Full Text] [Related]
13. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat.
Carini M; Aldini G; Orioli M; Piccoli A; Rossoni G; Maffei Facino R
Life Sci; 2004 May; 74(26):3291-305. PubMed ID: 15094329
[TBL] [Abstract][Full Text] [Related]
15. Hypertensive effects of oral administration of the aqueous extract of Solanum torvum fruits in L-NAME treated rats: evidence from in vivo and in vitro studies.
Nguelefack TB; Mekhfi H; Dongmo AB; Dimo T; Watcho P; Zoheir J; Legssyer A; Kamanyi A; Ziyyat A
J Ethnopharmacol; 2009 Jul; 124(3):592-9. PubMed ID: 19439171
[TBL] [Abstract][Full Text] [Related]
16. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats.
Muscará MN; McKnight W; Lovren F; Triggle CR; Cirino G; Wallace JL
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H528-35. PubMed ID: 10924050
[TBL] [Abstract][Full Text] [Related]
18. A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs.
Impagnatiello F; Borghi V; Gale DC; Batugo M; Guzzetta M; Brambilla S; Carreiro ST; Chong WK; Prasanna G; Chiroli V; Ongini E; Krauss AH
Exp Eye Res; 2011 Sep; 93(3):243-9. PubMed ID: 21356209
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide.
Moreira TS; Takakura AC; Sato MA; Menani JV; Colombari E
J Cardiovasc Pharmacol; 2006 Jun; 47(6):780-7. PubMed ID: 16810079
[TBL] [Abstract][Full Text] [Related]
20. Vasorelaxant and hypotensive effects of a hydroalcoholic extract from the fruits of Nitraria sibirica Pall. (Nitrariaceae).
Senejoux F; Girard C; Aisa HA; Bakri M; Kerram P; Berthelot A; Bévalot F; Demougeot C
J Ethnopharmacol; 2012 Jun; 141(2):629-34. PubMed ID: 21864668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
